As of 2025-07-04, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -6.94 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 13.01 USD, the upside of Edgewise Therapeutics Inc is -153.37%.
Based on its market price of 13.01 USD and our intrinsic valuation, Edgewise Therapeutics Inc (EWTX) is overvalued by 153.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.94 - -6.94 | -6.94 | -153.37% |
| P/E | (25.50) - (25.75) | (26.73) | -305.5% |
| DDM - Stable | (16.51) - (69.71) | (43.11) | -431.4% |
| DDM - Multi | (0.41) - (1.30) | (0.61) | -104.7% |
| Market Cap (mil) | 1,368.65 |
| Beta | 2.78 |
| Outstanding shares (mil) | 105.20 |
| Enterprise Value (mil) | 1,318.73 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.84% |
| Cost of Debt | 5.00% |
| WACC | 5.86% |